A better view of intraocular pressure.
IOVue is building the next generation of glaucoma monitoring. Our device offers a patient-friendly alternative to traditional tonometry — no air puff, no eye drops, and no corneal contact.
Designed for both clinical and at-home use, IOVue delivers real-time, continuous intraocular pressure (IOP) readings.
This is more than a new tool — it’s a smarter way to manage one of the leading causes of blindness worldwide.
With early detection and ongoing monitoring, physicians can intervene before irreversible vision loss occurs. Our platform is built for future expansion, with a core sensing technology that has the potential to revolutionize the detection and management of other worldwide health issues.
We’re currently in the R&D and regulatory phase, with FDA clearance and market launch projected in 2.5 years. With a strong IP position, experienced leadership, and a clear go-to-market plan, IOVue is positioned to transform glaucoma care and redefine the standard for ocular health monitoring.